Early research (Phase 1)Study completedNCT05926180
What this trial is testing
Assessing the Effect of DZD9008 on the Pharmacokinetics of the Cocktail Probes Representative for CYP3A4, P-gp, BCRP and OATP1B1 in Patients with EGFR or HER2 Mutant Advanced Non-small Cell Lung Cancer (WU-KONG19)
Who this might be right for
Non-small Cell Lung Cancer
Dizal Pharmaceuticals 25